Bitesize Breakthroughs
January 16, 2021
The latest eye-related research – in small chunks
1 min read
False
The Ophthalmologist’s March cover feature is all about an organ-to-cloud glaucoma project, the potential answer to ophthalmology’s glaucoma management problem. Our new, redesigned Upfront section features the latest research, innovations and trends in ophthalmology, from brain mapping diversity in eye dominance to tracing cataract surgery through the ages. In the In My View opinion columns, Jennifer Loh discusses her involvement in CEDARS/ASPENS and the importance of industry relationships to moving the field forward, and Kaweh Mansouri argues that glaucoma sub-specialty finds itself at a turning point. Our three In Practice articles discuss how mitomycin C shortages might affect glaucoma surgery, how surgical adjuncts can make cataract surgery safer and minimize costs, and how the joint-up approach improves quality of care for patients with diabetic eye diseases. Michael Stumpp presents the The DARPin platform for AMD and DME treatments in our NextGen section, while in the Profession department we talk to Scheffer C.G. Tseng about the key to boosting diversity in ophthalmology – Minority Mentoring Programs – and we kick off a new series, presenting ophthalmology’s most inspiring figures – beginning with the unsurpassable Fred Hollows. Finally, we sit down with Melissa Hunfalvay, former athlete and co-founder of RightEye.
January 16, 2021
The latest eye-related research – in small chunks
1 min read
March 16, 2020
Heidelberg Engineering’s glaucoma toolkit now includes two new features. Reintroducing… the SPECTRALIS® Glaucoma Module Premium Edition
1 min read
March 13, 2020
The glaucoma subspecialty is now at a turning point. But new approaches, including MIGS, must be based on high-quality evidence – and that means more randomized controlled trials.
1 min read
March 12, 2020
Organ-to-cloud technology is here – and it has its sights set on glaucoma. Offering a stream of objective, uncompromised data, it could revolutionize the glaucoma space… But for it to work, we need to rethink the way we assess therapy effectiveness in our current treatment paradigm.
1 min read
March 12, 2020
The DARPin platform has the AMD and DME treatment burden firmly in its sights – but that’s only the beginning
1 min read
March 11, 2020
Clark E. Tedford tells The Ophthalmologist about his part in creating LumiThera, its flagship product and technology, and the company’s plans for the future
1 min read
March 11, 2020
How important is a joint-up approach to caring for patients with diabetes and diabetic eye disease? We ask a diabetologist, an ophthalmologist, and their patient
1 min read
March 6, 2020
Rheon Medical’s eyeWatch device offers true pressure control in the surgical management of glaucoma
1 min read
March 3, 2020
Sitting Down With… Melissa Hunfalvay, Co-Founder and Chief Scientific Officer at RightEye, USA
1 min read
March 2, 2020
The retinal pigment epithelial patch edges closer to becoming a reality for dry AMD patients
1 min read
February 29, 2020
Ophthalmology needs a diversity boost – and minority mentoring programs could be the key
1 min read
February 27, 2020
In a new series, we present ophthalmology’s most inspiring figures, as told by those closest to them – beginning with the unsurpassable Fred Hollows
1 min read
February 26, 2020
CEDARS/ASPENS is an active network with clear mission in the anterior segment sphere: building knowledge, providing education, and fostering innovation
1 min read
February 24, 2020
Progress in ophthalmology doesn’t always come from increased complexity
1 min read
February 21, 2020
When it comes to brain mapping diversity, size – or rather, pattern – matters
1 min read
February 21, 2020
How surgical adjuncts can make cataract surgery safer – and minimize costs in the long run
1 min read
February 17, 2020
A newly-identified mutation in monkeys could spur development of cell and gene therapies for BBS
1 min read
February 17, 2020
Could the ELOVL2 gene be the key to new therapeutics for age-related eye diseases?
1 min read
False
False
False
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: